TRML
Income statement / Annual
Last year (2024), Tourmaline Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Tourmaline Bio, Inc.'s net income was -$73.21 M.
See Tourmaline Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$33,000.00
|
$6,000.00
|
$623,000.00
|
$447,000.00
|
$379,000.00
|
| Gross Profit |
$0.00
|
-$33,000.00
|
-$6,000.00
|
-$623,000.00
|
-$447,000.00
|
-$379,000.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$66.99 M
|
$32.37 M
|
$17.53 M
|
$212.00
|
$15.28 M
|
$13.37 M
|
| General & Administrative Expenses |
$22.75 M
|
$13.04 M
|
$2.18 M
|
$692.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.75 M
|
$13.04 M
|
$2.18 M
|
$692.00
|
$6.96 M
|
$4.63 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$89.73 M
|
$45.41 M
|
$19.70 M
|
$904.00
|
$22.24 M
|
$18.00 M
|
| Cost And Expenses |
$0.00
|
$45.41 M
|
$19.70 M
|
$904.00
|
$22.68 M
|
$18.38 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$223,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$23,000.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$33,000.00
|
$6,000.00
|
$904.00
|
$447,000.00
|
$379,000.00
|
| EBITDA |
-$89.73 M |
-$45.38 M |
-$19.70 M |
-$46.88 M |
-$22.24 M |
-$17.78 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$16.52 M
|
$3.29 M
|
$0.00
|
-$47.83 M
|
-$23,000.00
|
$223,000.00
|
| Income Before Tax |
-$73.21 M
|
-$42.12 M
|
-$19.70 M
|
-$904.00
|
-$22.71 M
|
-$18.16 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$73.21 M
|
$0.00
|
$0.00
|
-$47.21 M
|
$0.00
|
$0.00
|
| Net Income |
-$73.21 M
|
-$42.12 M
|
-$19.70 M
|
-$904.00
|
-$22.71 M
|
-$18.16 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.89 |
-8.87 |
-0.97 |
-0.0001 |
-33.97 |
-4.39 |
| EPS Diluted |
-2.89 |
-8.87 |
-0.97 |
-0.0001 |
-33.97 |
-4.39 |
| Weighted Average Shares Out |
$25.35 M
|
$4.75 M
|
$20.34 M
|
$10.88 M
|
$668,506.00
|
$4.13 M
|
| Weighted Average Shares Out Diluted |
$25.35 M
|
$4.75 M
|
$20.34 M
|
$10.88 M
|
$668,506.00
|
$4.13 M
|
| Link |
|
|
|
|
|
|
